Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) EBT (2018 - 2026)

AdaptHealth has reported EBT over the past 8 years, most recently at -$98.0 million for Q4 2025.

  • For Q4 2025, EBT fell 238.58% year-over-year to -$98.0 million; the TTM value through Dec 2025 reached -$15.2 million, down 111.14%, while the annual FY2025 figure was -$15.2 million, 111.14% down from the prior year.
  • EBT for Q4 2025 was -$98.0 million at AdaptHealth, down from $36.4 million in the prior quarter.
  • Over five years, EBT peaked at $92.4 million in Q2 2021 and troughed at -$487.5 million in Q3 2023.
  • A 5-year average of -$15.7 million and a median of $23.5 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: soared 996.25% in 2022 and later tumbled 8692.22% in 2023.
  • Year by year, EBT stood at $33.5 million in 2021, then plummeted by 90.56% to $3.2 million in 2022, then tumbled by 8692.22% to -$271.7 million in 2023, then surged by 126.03% to $70.7 million in 2024, then tumbled by 238.58% to -$98.0 million in 2025.
  • Business Quant data shows EBT for AHCO at -$98.0 million in Q4 2025, $36.4 million in Q3 2025, and $51.7 million in Q2 2025.